Nupsala Stem Cell Therapy
Advanced tissue regeneration treatments for orthopaedic injuries and ailments
From ponies to racehorses, stem cell therapy is becoming an increasingly common treatment for many equine injuries and ailments and is fast becoming the gold standard treatment for canine osteoarthritis. Autologous MSCs (mesenchymal stem cells) for use in the treatment are extracted from a sample of the patient’s bone marrow or adipose tissue. In horses this is done under standing sedation and local anaesthesia, for dogs a general anaesthetic is required.
The sample is sent to Nupsala’s laboratory partner where the stem cells are extracted and cultured - a process that takes around 14 days for canine cells and 21 days for equine. The cultured cells are returned to the veterinary surgeon for ultrasound guided implantation directly into the injury. A faster service is also available for canine stromal vascular fraction (SVF) treatments which are produced by preparing the cellular fraction from canine adipose tissue and returned to the vet within 48 hours.
The patient then undergoes a carefully controlled rehabilitation programme which takes approximately one year for horses and six months for dogs. This encourages a return to full fitness and, in the case of horses, full work or competition. Nupsala offers training to vets using this stem cell therapy for the first time, either on a one to one basis or group CPD training.
Stem cell therapy has been used to treat equine tendons, ligaments1&2 and joints (mainly stifle, some carpus, tarsus, distal DP, subchondral bone cysts, meniscal tears, fetlock problems, synovitis and early stage osteoarthritis). In recent years stem cells have started to be used very sucessfully for treating canine osteoarthritis3.